eLife assessment
The authors used the Multiethnic Cohort (MEC) study to study how COVID-19 impacted access to cancer screenings and treatment. This study's important findings served to identify key factors associated with cancer-related screening and healthcare-seeking during the pandemic. This investigation provides solid evidence to inform future policies, particularly in older and vulnerable populations.
Reviewer #1 (Public Review):
The purpose of this study was to investigate within the diverse Multiethnic Cohort (MEC) study on how COVID-19 impacted access to cancer screenings and treatment through a cross-sectional survey in this study population.
Major strengths were leveraging existing participants in a cohort study that contained a diverse population. The MEC cohort participants have been studied since the 90's. The investigators used a well-designed survey and performed analysis on responses focused on cancer screening attendance. Weaknesses of this study are low response rates that make the results not generalizable to other populations, especially younger populations, and possible bias of specific types of individuals responding.
This study found associations with racial/ethnic, age, comorbidities, and education to be key factors associated with cancer-related screening and healthcare seeking during the COVID-19 pandemic.
Whether the associations observed by the investigators would remain over time is unknown, as health care seeking changed as the pandemic evolved and prevention tools (including mass testing and vaccination) became available. It is important to note that this is a snapshot in time, so while it is informative, it will be important to monitor whether certain groups/populations that may be at high risk for cancer may need to be targeted for early diagnosis and screening.
